Michael Pollock

568 total citations
19 papers, 325 citations indexed

About

Michael Pollock is a scholar working on Molecular Biology, Nephrology and Surgery. According to data from OpenAlex, Michael Pollock has authored 19 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Nephrology and 5 papers in Surgery. Recurrent topics in Michael Pollock's work include Amyloidosis: Diagnosis, Treatment, Outcomes (12 papers), Parathyroid Disorders and Treatments (7 papers) and Orthopaedic implants and arthroplasty (3 papers). Michael Pollock is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (12 papers), Parathyroid Disorders and Treatments (7 papers) and Orthopaedic implants and arthroplasty (3 papers). Michael Pollock collaborates with scholars based in United States, Canada and Italy. Michael Pollock's co-authors include Brent A. Lanting, Lyndsay Somerville, Andrew Firth, Spencer Guthrie, Michelle K. White, Elizabeth J. Ackermann, Morie A. Gertz, Andrew O’Regan, Vikram Niranjan and Asia Sikora Kessler and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and Muscle & Nerve.

In The Last Decade

Michael Pollock

18 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Pollock United States 8 200 94 40 32 28 19 325
Simone Parri Italy 8 109 0.5× 65 0.7× 23 0.6× 6 0.2× 31 1.1× 13 274
Martin Kužma Slovakia 12 51 0.3× 95 1.0× 16 0.4× 25 0.8× 33 1.2× 51 403
Premlata K Varthakavi India 10 47 0.2× 46 0.5× 25 0.6× 14 0.4× 24 0.9× 32 239
Eda Özaydın Türkiye 9 76 0.4× 47 0.5× 25 0.6× 32 1.0× 4 0.1× 24 247
Kyoichi Hasegawa Japan 9 119 0.6× 36 0.4× 22 0.6× 18 0.6× 22 0.8× 13 257
Julia M. Carlson United States 10 40 0.2× 173 1.8× 43 1.1× 26 0.8× 48 1.7× 22 288
Balram Sharma India 9 227 1.1× 36 0.4× 43 1.1× 5 0.2× 8 0.3× 28 371
Ruifei Yang China 6 40 0.2× 79 0.8× 18 0.5× 12 0.4× 24 0.9× 10 313
Mary Garthwaite United Kingdom 9 162 0.8× 64 0.7× 18 0.5× 40 1.3× 3 0.1× 15 294
Daisuke Sato Japan 9 68 0.3× 51 0.5× 20 0.5× 53 1.7× 9 0.3× 58 253

Countries citing papers authored by Michael Pollock

Since Specialization
Citations

This map shows the geographic impact of Michael Pollock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Pollock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Pollock more than expected).

Fields of papers citing papers by Michael Pollock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Pollock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Pollock. The network helps show where Michael Pollock may publish in the future.

Co-authorship network of co-authors of Michael Pollock

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Pollock. A scholar is included among the top collaborators of Michael Pollock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Pollock. Michael Pollock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Raymond, Kimberly, et al.. (2021). Patient-reported burden of hereditary transthyretin amyloidosis on functioning and well-being. Journal of Patient-Reported Outcomes. 5(1). 3–3. 14 indexed citations
2.
Vera‐Llonch, Montserrat, et al.. (2021). The patient journey toward a diagnosis of hereditary transthyretin (ATTRv) amyloidosis. Orphanet Journal of Rare Diseases. 16(1). 25–25. 11 indexed citations
3.
O’Regan, Andrew, et al.. (2021). ABC of prescribing exercise as medicine: a narrative review of the experiences of general practitioners and patients. BMJ Open Sport & Exercise Medicine. 7(2). e001050–e001050. 15 indexed citations
4.
Dyck, P. James B., John C. Kincaid, Janice F. Wiesman, et al.. (2020). mNIS+7 and lower limb function in inotersen treatment of hereditary transthyretin‐mediated amyloidosis. Muscle & Nerve. 62(4). 502–508. 8 indexed citations
5.
Dyck, P. James B., Teresa Coelho, Márcia Waddington‐Cruz, et al.. (2020). Neuropathy symptom and change: Inotersen treatment of hereditary transthyretin amyloidosis. Muscle & Nerve. 62(4). 509–515. 15 indexed citations
6.
Reddy, Sheila R., Eunice Chang, Michael S. Broder, et al.. (2020). The Clinical and Economic Burden of Newly Diagnosed Hereditary Transthyretin (ATTRv) Amyloidosis: A Retrospective Analysis of Claims Data. Neurology and Therapy. 9(2). 473–482. 6 indexed citations
7.
Ortiz‐Pérez, Jose T., Sheila R. Reddy, Eunice Chang, et al.. (2020). Cardiovascular Disease Burden Prior To Hereditary Transthyretin Amyloidosis Diagnosis. Journal of Cardiac Failure. 26(10). S125–S126. 1 indexed citations
8.
Yarlas, Aaron, Morie A. Gertz, Noel R. Dasgupta, et al.. (2019). Burden of hereditary transthyretin amyloidosis on quality of life. Muscle & Nerve. 60(2). 169–175. 36 indexed citations
9.
Kessler, Asia Sikora, Aaron Yarlas, Kristen McCausland, et al.. (2019). CLINICAL OUTCOME ASSESSMENT SCORES FOR PATIENTS WITH TRANSTHYRETIN AMYLOIDOSIS WITH OR WITHOUT ACCOMPANYING CARDIOMYOPATHY OR CONGESTIVE HEART FAILURE. Journal of the American College of Cardiology. 73(9). 864–864. 1 indexed citations
10.
Kessler, Asia Sikora, Aaron Yarlas, Michael Pollock, Spencer Guthrie, & Kristen McCausland. (2019). Characterizing the Journey to Diagnosis for Patients with Transthyretin Amyloidosis and Accompanying Congestive Heart Failure. Journal of Cardiac Failure. 25(8). S60–S60. 3 indexed citations
11.
Keir, Daniel A., Michael Pollock, Donald H. Paterson, et al.. (2018). Slow V ˙ O 2 kinetics in acute hypoxia are not related to a hyperventilation-induced hypocapnia. Respiratory Physiology & Neurobiology. 251. 41–49. 5 indexed citations
12.
Pollock, Michael, et al.. (2018). Optimizing outpatient total hip arthroplasty: perspectives of key stakeholders. Canadian Journal of Surgery. 61(6). 370–376. 24 indexed citations
13.
Pollock, Michael. (2018). GRABBING THE THIRD RAIL: AS GAMING EVOLVES, TAX POLICY NEEDS TO KEEP PACE. 22(3). 175–177. 1 indexed citations
14.
Brannagan, Thomas H., Annabel K. Wang, Teresa Coelho, et al.. (2018). Long-Term Update from the Open-Label Extension of the NEURO-TTR Study in Patients with Hereditary Transthyretin Amyloidosis. Blood. 132(Supplement 1). 498–498. 4 indexed citations
15.
Yarlas, Aaron, Giampaolo Merlini, Michelle K. White, et al.. (2018). Impact of Inotersen on Subgroups of Patients with Hereditary TTR Amyloidosis: Results from a Double-Blind Placebo-Controlled Trial. Blood. 132(Supplement 1). 4803–4803. 1 indexed citations
16.
Yarlas, Aaron, Giampaolo Merlini, Michelle K. White, et al.. (2018). Impact of Inotersen on Functioning and Activities of Daily Living for Patients with Hereditary TTR Amyloidosis: Results from a Double-Blind Placebo-Controlled Trial. Blood. 132(Supplement 1). 4812–4812. 1 indexed citations
17.
Pollock, Michael. (2016). Inpatient versus Outpatient Total Hip Arthroplasty. Scholarship@Western (Western University). 1 indexed citations
18.
Pollock, Michael, Lyndsay Somerville, Andrew Firth, & Brent A. Lanting. (2016). Outpatient Total Hip Arthroplasty, Total Knee Arthroplasty, and Unicompartmental Knee Arthroplasty. JBJS Reviews. 4(12). 176 indexed citations
19.
Pollock, Michael, et al.. (1999). Health Economics in the Canadian Pharmaceutical Industry. PharmacoEconomics. 16(6). 669–678. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simone Parri Breakdown of academic impact, for papers by Martin Kužma Breakdown of academic impact, for papers by Premlata K Varthakavi Breakdown of academic impact, for papers by Eda Özaydın Breakdown of academic impact, for papers by Kyoichi Hasegawa Breakdown of academic impact, for papers by Julia M. Carlson Breakdown of academic impact, for papers by Balram Sharma Breakdown of academic impact, for papers by Ruifei Yang Breakdown of academic impact, for papers by Mary Garthwaite Breakdown of academic impact, for papers by Daisuke Sato
Rankless by CCL
2026